Bank of New York Mellon
INBX

Bank of New York Mellon’s Inhibrx, Inc. Common Stock INBX Stock Holding History

Bank of New York Mellon’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-108,369
Closed -$3.79M – 4344
2024
Q1 		$3.79M Sell
108,369
-6,456
-6% -$235K ﹤0.01% 2451
2023
Q4 		$4.36M Buy
114,825
+437
+0.4% +$9.36K ﹤0.01% 2443
2023
Q3 		$2.1M Sell
114,388
-908
-0.8% -$19K ﹤0.01% 2781
2023
Q2 		$2.99M Buy
115,296
+9,919
+9% +$232K ﹤0.01% 2609
2023
Q1 		$1.99M Sell
105,377
-2,137
-2% -$49.7K ﹤0.01% 2811
2022
Q4 		$2.65M Buy
107,514
+10,565
+11% +$311K ﹤0.01% 2699
2022
Q3 		$1.74M Buy
96,949
+14,202
+17% +$256K ﹤0.01% 2933
2022
Q2 		$938K Sell
82,747
-3,427
-4% -$50.4K ﹤0.01% 3249
2022
Q1 		$1.92M Buy
86,174
+1,017
+1% +$26K ﹤0.01% 2959
2021
Q4 		$3.72M Sell
85,157
-938
-1% -$37.5K ﹤0.01% 2621
2021
Q3 		$2.87M Buy
86,095
+25,935
+43% +$789K ﹤0.01% 2786
2021
Q2 		$1.66M Buy
60,160
+32,462
+117% +$676K ﹤0.01% 3126
2021
Q1 		$556K Sell
27,698
-118
-0.4% -$3.45K ﹤0.01% 3630
2020
Q4 		$917K Buy
+27,816
New +$740K ﹤0.01% 3298

Other funds holding INBX

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Bank of New York Mellon's INBX Position: Q2 2024 in Review

Bank of New York Mellon sold out of Inhibrx, Inc. Common Stock (INBX) in Q2 2024, closing a stake of 108,369 shares — an estimated $3.79M sold.

Bank of New York Mellon first reported a position in INBX in Q4 2020 and held it in 14 quarters. The position peaked at $4.36M in Q4 2023. 2 funds tracked by Wall St. Rank hold INBX as of Q2 2024.

  • Bank of New York Mellon reported no remaining Inhibrx, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Bank of New York Mellon sold 108,369 Inhibrx, Inc. Common Stock shares in Q2 2024, an estimated $3.79M.
  • Bank of New York Mellon first reported a position in Inhibrx, Inc. Common Stock in Q4 2020 and held it in 14 quarters.
  • Bank of New York Mellon's Inhibrx, Inc. Common Stock position peaked at $4.36M in Q4 2023.
  • 2 funds tracked by Wall St. Rank held Inhibrx, Inc. Common Stock as of Q2 2024.

Based on Bank of New York Mellon's 13F filing for Q2 2024, filed 25 Jul 2024.